Facial and Waxing Request from a Client on Oral Isotretinoin
A 24-year-old client books a 'deep-clean facial and full-face wax' three days before a wedding. At consultation she says she started oral isotretinoin 20 mg daily eight weeks ago for severe acne. She had not mentioned this when booking. Her skin is dry and flaky around the nose and mouth, with visible erythema on the cheeks; she has two healing papules but no open sores. She wants eyebrow shaping, upper-lip wax, and a salicylic acid peel added to the facial because she has 'read it clears pores'. She is also using benzoyl peroxide 5% nightly. She has signed the salon's general consent form, which does not list isotretinoin. She is insistent because the wedding is in 72 hours. She has no known allergies and has had waxing before without reaction.
1. Identify the contraindications and explain the skin biology behind each.
Read the worked answer
The main contraindication is oral isotretinoin. It reduces sebum production and thins the epidermis and stratum corneum, so the skin's barrier is less cohesive and heals more slowly. Waxing on this skin can strip living epidermis as well as hair, causing erosions, burns, post-inflammatory hyperpigmentation, infection and possible scarring. The risk persists during treatment and for a period after the last dose; current guidance commonly advises avoiding waxing for at least six months after stopping, and the prescriber should be consulted.
Salicylic acid peel is also inappropriate. The barrier is already compromised by dryness and erythema, and a peel increases penetration of an acid that can irritate and cause further desquamation. Benzoyl peroxide 5% adds dryness and irritation, increasing the chance of a reaction. Eyebrow shaping is not automatically forbidden, but the skin around the brows is also treated skin; mechanical trauma can cause the same problems. The general consent form is inadequate because it did not capture a medication that changes the risk assessment. The correct judgement is to decline waxing and the peel, not to 'patch test and proceed'.
2. What treatment, if any, can you offer today, and what would you tell her about timing?
Read the worked answer
I would offer only a gentle, calming facial if her skin is comfortable with it: lukewarm cleanse, gentle massage without extractions, a simple hyaluronic-acid or glycerin moisturiser, and broad-spectrum sunscreen. No steam, no heat, no scrubs, no enzymes, no extractions, no acids and no newly introduced active ingredients. I would patch-test any product I had not used on her before, even in a gentle facial. If the skin is stinging or visibly inflamed, the safest option is no facial at all and simple home aftercare.
For the wedding, I would explain that the best result comes from not injuring the skin now. I would suggest a makeup appointment rather than a resurfacing treatment and advise her to keep her routine simple until the event. For future waxing, she should discuss timing with her prescriber and wait until the skin has normalised after stopping isotretinoin - commonly at least six months, but the prescriber's advice takes priority. I would not promise that a peel will be safe later; that depends on medical clearance and a fresh consultation.
3. What should be documented, and what should you do about the consent form?
Read the worked answer
Document the medication name, dose, start date, prescriber, and the fact that it was disclosed at consultation rather than at booking. Record the skin observations - dryness, flaking, erythema, healing papules - and the treatments declined, the reasons given, the alternatives offered, and the aftercare advice. Note that the client was advised to consult her prescriber about timing for waxing and peels. Record the patch test if one was done. Sign and date the entry.
I would not alter or backdate the existing consent form. I would update the salon's consultation form so that isotretinoin and other systemic retinoids are explicitly listed, and use a new form for future visits. The signed general consent does not cover a treatment that became contraindicated once the medication was disclosed. Good documentation protects the client and demonstrates that the decision was based on a proper risk assessment, not on convenience.